PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,205,000 | -2.8% | 500,000 | +65.5% | 2.04% | -9.7% |
Q4 2022 | $11,532,493 | -31.1% | 302,135 | -8.4% | 2.26% | +68.9% |
Q2 2020 | $16,744,000 | -78.7% | 330,000 | -81.3% | 1.34% | -83.7% |
Q1 2020 | $78,665,000 | -6.4% | 1,763,387 | +0.8% | 8.22% | +12.3% |
Q4 2019 | $84,053,000 | +24.3% | 1,750,000 | -12.5% | 7.32% | +17.8% |
Q3 2019 | $67,640,000 | -99.9% | 2,000,000 | +1.3% | 6.21% | -37.0% |
Q2 2019 | $88,847,000,000 | +130004.4% | 1,974,385 | +8.8% | 9.86% | +45.9% |
Q1 2019 | $68,289,000 | +62.4% | 1,814,260 | +48.1% | 6.76% | +27.2% |
Q4 2018 | $42,042,000 | +24.7% | 1,225,000 | +70.7% | 5.31% | +1.1% |
Q3 2018 | $33,721,000 | -36.3% | 717,458 | -54.3% | 5.26% | -28.3% |
Q2 2018 | $52,906,000 | -99.9% | 1,568,500 | -9.8% | 7.33% | +4.9% |
Q1 2018 | $47,080,000,000 | +259852.5% | 1,739,822 | +60.2% | 6.99% | +126.3% |
Q4 2017 | $18,111,000 | -42.0% | 1,085,800 | -30.4% | 3.09% | -49.1% |
Q3 2017 | $31,216,000 | -21.2% | 1,560,000 | -27.8% | 6.07% | -14.4% |
Q2 2017 | $39,593,000 | +174.0% | 2,160,000 | +47.1% | 7.09% | +147.1% |
Q1 2017 | $14,450,000 | – | 1,468,521 | – | 2.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |